Devon Evans

1.1k total citations
34 papers, 729 citations indexed

About

Devon Evans is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Devon Evans has authored 34 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Devon Evans's work include Lung Cancer Treatments and Mutations (7 papers), Uterine Myomas and Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Devon Evans is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Uterine Myomas and Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Devon Evans collaborates with scholars based in United States, Canada and Italy. Devon Evans's co-authors include Howard Safran, Paul Akerman, Jane Leserman, Carol Murphy, Diana O. Perkins, T. A. Kennedy, Thomas Ng, Thomas A. DiPetrillo, David J. Hall and B. Zheng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Devon Evans

34 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devon Evans United States 14 244 217 160 157 98 34 729
Han Han China 14 246 1.0× 84 0.4× 75 0.5× 175 1.1× 72 0.7× 46 648
Gary M. Dosik United States 13 399 1.6× 149 0.7× 116 0.7× 184 1.2× 44 0.4× 17 959
Caroline Hoffmann France 19 164 0.7× 405 1.9× 305 1.9× 229 1.5× 55 0.6× 66 1.2k
Priya Gopalan United States 15 333 1.4× 181 0.8× 62 0.4× 411 2.6× 83 0.8× 43 1.5k
Liane Esteves Daudt Brazil 15 212 0.9× 94 0.4× 156 1.0× 201 1.3× 43 0.4× 71 1.1k
Michael B. Foote United States 13 232 1.0× 90 0.4× 43 0.3× 207 1.3× 101 1.0× 42 656
Qianqian Zhao China 17 463 1.9× 190 0.9× 249 1.6× 147 0.9× 29 0.3× 55 1.1k
Renata R. Urban United States 20 409 1.7× 100 0.5× 337 2.1× 140 0.9× 133 1.4× 77 1.6k
Nguyen Le Bao Tien Vietnam 13 161 0.7× 33 0.2× 121 0.8× 222 1.4× 147 1.5× 19 839
Filippo Pederzoli Italy 25 183 0.8× 177 0.8× 532 3.3× 407 2.6× 26 0.3× 85 1.5k

Countries citing papers authored by Devon Evans

Since Specialization
Citations

This map shows the geographic impact of Devon Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devon Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devon Evans more than expected).

Fields of papers citing papers by Devon Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devon Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devon Evans. The network helps show where Devon Evans may publish in the future.

Co-authorship network of co-authors of Devon Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Devon Evans. A scholar is included among the top collaborators of Devon Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devon Evans. Devon Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Catherine, et al.. (2024). Placenta Accreta Spectrum Disorders: A Canadian Tertiary Care Centre’s Experience Over 10 years. Journal of Obstetrics and Gynaecology Canada. 47(3). 102757–102757. 1 indexed citations
2.
Leyland, Nicholas, et al.. (2024). Guideline No. 453: Endometrial Ablation in the Management of Abnormal Uterine Bleeding. Journal of Obstetrics and Gynaecology Canada. 46(9). 102641–102641. 1 indexed citations
3.
Shirreff, Lindsay, et al.. (2021). Impact of Minimally Invasive Gynaecology Fellowship Training on Quality Performance Metrics for Hysterectomy. Journal of Obstetrics and Gynaecology Canada. 43(12). 1364–1371. 7 indexed citations
4.
Singh, Sukhbir S., et al.. (2020). Ulipristal Acetate Prior to Surgery for Endometriosis. Reproductive Sciences. 27(9). 1707–1714. 8 indexed citations
5.
Evans, Devon, et al.. (2019). No. 385-Indications for Pelvic Examination. Journal of Obstetrics and Gynaecology Canada. 41(8). 1221–1234. 13 indexed citations
6.
Evans, Devon, et al.. (2019). No 385 - Indications de l'examen pelvien. Journal of Obstetrics and Gynaecology Canada. 41(8). 1235–1250. 1 indexed citations
7.
Jeyapalan, Suriya, Jerrold L. Boxerman, John E. Donahue, et al.. (2013). Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma. American Journal of Clinical Oncology. 37(5). 444–449. 40 indexed citations
8.
Jeyapalan, Suriya, John E. Donahue, Heinrich Elinzano, et al.. (2011). A phase II study of paclitaxel poliglumex (PPX), temozolamide (TMZ), and radiation (RT) for newly diagnosed high-grade gliomas.. Journal of Clinical Oncology. 29(15_suppl). 2036–2036. 6 indexed citations
9.
Safran, Howard, Mohan Suntharalingam, Thomas Ng, et al.. (2008). Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity. International Journal of Radiation Oncology*Biology*Physics. 70(2). 391–395. 83 indexed citations
10.
Safran, Howard, Thomas J. Miner, Murray B. Resnick, et al.. (2008). Lapatinib/Gemcitabine and Lapatinib/Gemcitabine/Oxaliplatin. American Journal of Clinical Oncology. 31(2). 140–144. 33 indexed citations
11.
Evans, Devon, et al.. (2007). A Phase I Study of Docetaxel, Oxaliplatin, and Capecitabine in Patients With Metastatic Gastroesophageal Cancer. American Journal of Clinical Oncology. 30(4). 346–349. 17 indexed citations
12.
Evans, Devon, Thomas J. Miner, David A. Iannitti, et al.. (2007). Docetaxel, Capecitabine and Carboplatin in Metastatic Esophagogastric Cancer: A Phase II Study. Cancer Investigation. 25(6). 445–448. 11 indexed citations
13.
Milas, Luka, Devon Evans, Paul Akerman, et al.. (2006). Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer. American Journal of Clinical Oncology. 29(4). 376–379. 56 indexed citations
14.
Safran, Howard, Thomas A. DiPetrillo, Paul Akerman, et al.. (2006). Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 67(2). 405–409. 88 indexed citations
15.
Evans, Devon, et al.. (2003). Purification of Supercoiled Plasmid DNA. Humana Press eBooks. 94. 41–50. 1 indexed citations
16.
Evans, Devon, et al.. (2002). Breast Enlargement in 13 Men Who Were Seropositive for Human Immunodeficiency Virus. Clinical Infectious Diseases. 35(9). 1113–1119. 26 indexed citations
17.
Hann, Christine L., Devon Evans, Jolanta Fertala, et al.. (1998). Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I. Journal of Biological Chemistry. 273(14). 8425–8433. 42 indexed citations
18.
Evans, Devon, et al.. (1997). Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor.. PubMed. 65(1). 83–94. 4 indexed citations
19.
Evans, Devon, et al.. (1997). Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor. Journal of Cellular Biochemistry. 65(1). 83–94. 2 indexed citations
20.
Perkins, Diana O., Jane Leserman, Carol Murphy, & Devon Evans. (1993). Psychosocial Predictors of High-Risk Sexual Behavior Among HIV-Negative Homosexual Men. AIDS Education and Prevention. 5(2). 141–152. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Han Breakdown of academic impact, for papers by Gary M. Dosik Breakdown of academic impact, for papers by Caroline Hoffmann Breakdown of academic impact, for papers by Priya Gopalan Breakdown of academic impact, for papers by Liane Esteves Daudt Breakdown of academic impact, for papers by Michael B. Foote Breakdown of academic impact, for papers by Qianqian Zhao Breakdown of academic impact, for papers by Renata R. Urban Breakdown of academic impact, for papers by Nguyen Le Bao Tien Breakdown of academic impact, for papers by Filippo Pederzoli
Rankless by CCL
2026